This report studies the global market size of Precision Medicine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Precision Medicine in these regions.
This research report categorizes the global Precision Medicine market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.
According to the National Institutes of Health (NIH), precision medicine is "an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person." This approach will allow doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people. It is in contrast to a "one-size-fits-all" approach, in which disease treatment and prevention strategies are developed for the average person, with less consideration for the differences between individuals.
Although the term "precision medicine" is relatively new, the concept has been a part of healthcare for many years. For example, a person who needs a blood transfusion is not given blood from a randomly selected donor; instead, the donors blood type is matched to the recipient to reduce the risk of complications. Although examples can be found in several areas of medicine, the role of precision medicine in day-to-day healthcare is relatively limited. Researchers hope that this approach will expand to many areas of health in coming years.
The classification of precision medicine includes diagnostics and therapies, and the proportion of diagnostics in 2016 is about 68%.
Precision Medicine is used for oncology, neurosciences, immunology, respiratory and other field. The most proportion of precision medicine is for oncology, and the revenue in 2016 is 4.3 billion USD.
Germany is the largest consumption place, with a consumption market share nearly 22% in 2016. Following Germany, France is the second largest consumption place with the consumption market share of 18%.
In 2017, the global Precision Medicine market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Precision Medicine market based on company, product type, application and key regions.
The various contributors involved in the value chain of Precision Medicine include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Precision Medicine include
Johnson & Johnson
IBM
GE Healthcare
Illumina
Roche
Laboratory Corporation of America Holdings
Thermo Fisher Scientific
Novartis
Abbott Laboratories
Almac Group
Intel Corporation
Biomrieux Sa
Cepheid
Qiagen
Randox Laboratories
Healthcore
Market Size Split by Type
Diagnostics
Therapies
Market Size Split by Application
Oncology
Neurosciences
Immunology
Respiratory
Others
Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Precision Medicine market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Precision Medicine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Precision Medicine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Precision Medicine with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Precision Medicine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Precision Medicine are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Precision Medicine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Precision Medicine Market, By Application
7.1. Precision Medicine Market, by Application, 2021-2028
7.1.1. Diagnostics
7.1.1.1. Market Revenue and Forecast (2016-2028)
7.1.2. Therapeutics
7.1.2.1. Market Revenue and Forecast (2016-2028)
7.1.3. Medical Devices
7.1.3.1. Market Revenue and Forecast (2016-2028)
Chapter 8. Global Precision Medicine Market, End Use
8.1. Precision Medicine Market, End Use, 2021-2028
8.1.1. Home care
8.1.1.1. Market Revenue and Forecast (2016-2028)
8.1.2. Hospitals
8.1.2.1. Market Revenue and Forecast (2016-2028)
8.1.3. Clinical Laboratories
8.1.3.1. Market Revenue and Forecast (2016-2028)
Chapter 9. Global Precision Medicine Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Application (2016-2028)
9.1.2. Market Revenue and Forecast, End Use (2016-2028)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Application (2016-2028)
9.1.3.2. Market Revenue and Forecast, End Use (2016-2028)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Application (2016-2028)
9.1.4.2. Market Revenue and Forecast, End Use (2016-2028)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Application (2016-2028)
9.2.2. Market Revenue and Forecast, End Use (2016-2028)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Application (2016-2028)
9.2.3.2. Market Revenue and Forecast, End Use (2016-2028)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Application (2016-2028)
9.2.4.2. Market Revenue and Forecast, End Use (2016-2028)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Application (2016-2028)
9.2.5.2. Market Revenue and Forecast, End Use (2016-2028)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Application (2016-2028)
9.2.6.2. Market Revenue and Forecast, End Use (2016-2028)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Application (2016-2028)
9.3.2. Market Revenue and Forecast, End Use (2016-2028)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Application (2016-2028)
9.3.3.2. Market Revenue and Forecast, End Use (2016-2028)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Application (2016-2028)
9.3.4.2. Market Revenue and Forecast, End Use (2016-2028)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Application (2016-2028)
9.3.5.2. Market Revenue and Forecast, End Use (2016-2028)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Application (2016-2028)
9.3.6.2. Market Revenue and Forecast, End Use (2016-2028)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Application (2016-2028)
9.4.2. Market Revenue and Forecast, End Use (2016-2028)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Application (2016-2028)
9.4.3.2. Market Revenue and Forecast, End Use (2016-2028)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Application (2016-2028)
9.4.4.2. Market Revenue and Forecast, End Use (2016-2028)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Application (2016-2028)
9.4.5.2. Market Revenue and Forecast, End Use (2016-2028)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Application (2016-2028)
9.4.6.2. Market Revenue and Forecast, End Use (2016-2028)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Application (2016-2028)
9.5.2. Market Revenue and Forecast, End Use (2016-2028)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Application (2016-2028)
9.5.3.2. Market Revenue and Forecast, End Use (2016-2028)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Application (2016-2028)
9.5.4.2. Market Revenue and Forecast, End Use (2016-2028)
Chapter 10. Company Profiles
10.1. Abbott Laboratories
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Biogen Inc.
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Foundation Medicine Inc.
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Illumina, Inc.
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Precision Biologics
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. IBM Watson
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Siemens Healthineers
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Janssen Pharmaceuticals
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. GE Healthcare.
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers